Management of organophosphorus pesticide poisoning

Toxicology of Organophosphate & Carbamate Compounds

Volumn , Issue , 2006, Pages 715-733

  Marrs, Timothy C ^a,b   Vale, J Allister ^c  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b National Poisons Information Service   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68449085847     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088523-7/50050-8     Document Type: Chapter

References (164)

1. Aaltonen L., Kanto J., Iisalo E., Pihlajamaki K. Comparison of radioreceptor assay and radioimmunoassay for atropine: Pharmacokinetic application. Eur. J. Clin. Pharmacol. 1984, 26:613-617.
2. Alkondon M., Rao K.S., Albuquerque E.X. Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel. J. Pharmacol. Exp. Ther. 1988, 245:543-556.
3. Anderson D.R., Harris L.W., Chang F.-C.T., Baze W.B., Capacio B.R., Byers S.L., Lennox W.J. Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine. Drug Chem. Toxicol. 1997, 20:115-131.
4. Andreasen P.B., Hendel J., Greisen G., Hvidberg E.F. Pharmacokinetics of diazepam in disordered liver function. Eur. J. Clin. Pharmacol. 1976, 10:115-120.
5. Ballantyne B., Gazzard M.F., Robson D.C., Swanston D.W. Concentrations of 2-hydroxyiminomethyl-N-methylpyridinium ion in plasma and aqueous humor as indices of the toxicity of pralidoxime mesylate (P2S) for the rabbit. Toxicol. Appl. Pharmacol. 1975, 33:559-567.
6. Barckow D., Neuhaus G., Erdmann W.D. Zur Behandlung der schweren Parathion-(E605(R))-Vergiftung mit dem Cholinesterase-Reaktivator Obidoxim (Toxogonin(R)). Arch. Toxikol. 1969, 24:133-146.
7. Bardin P.G., Van Eeden S.F., Joubert J.R. Intensive care management of acute organophosphatc poisoning. A 7-year experience in the western Cape. S. Afr. Med. J. 1987, 72:593-597.
8. Berghem L., Bergman U., Schildt B., Sorbo B. Plasma atropine concentrations determined by radioimmunoassay after single-dose i.v. and i.m. administration. Br. J. Anaesth. 1980, 52:597-601.
9. Berglund F., Elwin C.-E., Sundwall A. Studies on the renal elimination of N-methylpyridinium-2-aldoxime. Biochem. Pharmacol. 1962, 11:383-388.
10. Bisa K., Fischer G., Müller O., Oldiges H., Zoch E. Die Antidotwirkung von Bis-[4-hydroxyiminomethyl-pyridinium-(1)-methyl]-äther-dichlorid bei mit Alkylphosphat vergifteten Ratten. Arzneimittelforschung 1964, 14:85-88.
11. Bismuth C., Inns R.H., Marrs T.C. Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 555-577. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
12. Boelcke G., Gaaz J.-W. Zur Frage der Lebertoxicität von Nitrostigmin (E 605 forte) und Obidoxim (Toxogonin) an Hunden. Arch. Toxikol. 1970, 26:93-101.
13. Boelcke G., Kamphenkel L. Der Einfluß der Nitrostigmin-Vergiftung und der spezifischen Antidote-Therapie mit Obidoxim auf die Bilirubin-Clearance und den Gallefluß der Ratte. Arch. Toxikol. 1970, 26:210-219.
14. Bokonjic D., Jovanovic D., Jokanovic M., Maksimovic M. Protective effects of oximes HI-6 and PAM-2 applied by osmotic minipumps in quinalphos-poisoned rats. Arch. Int. Pharmacodyn. Ther. 1987, 288:309-318.
15. Broomfield C.A., Lockridge O., Millard C.B. Protein engineering of a human enzyme that hydrolyzes V and G nerve agents: Design, construction and characterization. Chem.-Biol. Interact. 1999, 119-120:413-418.
16. Burgen A.S.V., Hobbiger F. The inhibition of cholinesterases by alkylphosphates and alkylphenolphosphates. Br. J. Pharmacol. 1951, 6:593-605.
17. Calesnick B., Christensen J.A., Richter M. Human toxicity of various oximes. 2-Pyridine aldoxime methyl chloride, its methane sulfonate salt, and 1,1'-trimethylenebis-(4-formylpyridinium chloride). Arch. Environ. Health 1967, 15:599-608.
18. Casey P.B., Blakey L., Bradberry S.M., Vale J.A. Late reactivation of erythrocyte cholinesterase activity by pralidoxime in a case of chlorpyrifos poisoning. Przegl. Lek. 1995, 52:206.
19. Casey P.B., Gosden E., Blakey L., Thompson J.P., Vale J.A. Plasma pralidoxime concentrations following bolus injection and continuous infusion. Przegl. Lek. 1995, 52:203-204.
20. Cavaliere M.J., Puga F.R., Calore E.E., Calore N.M.P., Pelegrino J.d. R., Da Rosa A.R., Weg R. Protective effect of pralidoxime on muscle fiber necrosis induced by organophosphate compounds. J. Toxicol. Clin. Toxicol. 1998, 36:295-300.
21. Charney D.S., Mihic S.J., Harris R.A. Hypnotics and sedatives. Goodman & Gilmans' The Pharmacological Basis of Therapeutics 2001, 399-427. McGraw-Hill, New York. 10th ed. J.G. Hardman, L.E. Limbird, A.G. Gilman (Eds.).
22. Crook J.W., Goodman A.I., Colbourn J.L., Zvirblis P., Oberst F.W., Wills J.H. Adjunctive value of oral prophylaxis with the oximes 2-PAM lactate and 2-PAM methanesulfonate to therapeutic administration of atropine in dogs poisoned by inhaled sarin vapor. J. Pharmacol. Exp. Ther. 1962, 136:397-399.
23. Darvesh S., Hopkins D.A., Geula C. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 2003, 4:131-138.
24. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 1994, 14:317-331.
25. de Jong L.P.A., Ceulen D.I. Anticholinesterase activity and rate of decomposition of some phosphylated oximes. Biochem. Pharmacol. 1978, 27:857-863.
26. de Jong L.P.A., Wolring G.Z., Benschop H.P. Reactivation of acetylcholinesterase inhibited by methamidophos and analogous (di)methylphosphoramidates. Arch. Toxicol. 1982, 49:175-183.
27. de Jong L.P.A., Verhagen M.A.A., Langenberg J.P., Hagedorn I., Löffler M. The bispyridiniumdioxime HLö-7. A potent reactivator for acetylcholinesterase inhibited by the stereoisomers of tabun and soman. Biochem. Pharmacol. 1989, 38:633-640.
28. de Kort W.L.A.M., Kiestra S.H., Sangster B. The use of atropine and oximes in organophosphate intoxications: A modified approach. J. Toxicol. Clin. Toxicol. 1988, 26:199-208.
29. Dekundy A., Blaszczak P., Kaminski R., Turski W.A. On the interactions between antimuscarinic atropine and NMDA receptor antagonists in anticholinesterase-treated mice. Arch. Toxicol. 2001, 74:702-708.
30. De Silva H.J., Wijewickrema R., Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning?. Lancet 1992, 339:1136-1138.
31. Diamantis W., Kletzkin M. Evaluation of muscle relaxant drugs by head-drop and by decerebrate rigidity. Int. J. Neuropharmacol. 1966, 5:305-310.
32. Dretchen K.L., Henderson T.R., Raines A. Calcium blockdng agents in the management of acute anticholinesterase poisoning. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 587-595. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
33. DuToit P.W., Muller F.O., van Tonder W.M., Ungerer M.J. Experience with the intensive care management of organophosphate insecticide poisoning. S. Afr. Med. J. 1981, 60:227-229.
34. Eddleston M., Szinicz L., Eyer P., Buckley N. Oximes in acute organophosphorus pesticide poisoning: A systematic review of clinical trials. QJM 2002, 95:275-283.
35. Edwards P. Factors influencing organophosphate toxicity in humans. Organophosphates and Health 2001, 61-81. Imperial College Press, London. L. Karalliedde, S. Feldman, J. Henry, T. Marrs (Eds.).
36. Ellin R.I., GroffW.A., Sidell F.R. Passage of pyridinium oximes into human red cells. Biochem. Pharmacol. 1974, 23:2663-2670.
37. Enander I., Sundwall A., Sörbo B. Metabolic studies on N-methylpyridinium-2-aldoxime. I. The conversion to thiocyanate. Biochem. Pharmacol. 1961, 7:226-231.
38. Finkelstein Y., Kushnir A., Raikhlin-Eisenkraft B., Taitelman U. Antidotal therapy of severe acute organophosphate poisoning: A multihospital study. Neurotoxicol. Teratol. 1989, 11:593-596.
39. Food and Agriculture Organization/World Health Organization Pesticide Residues in Food: 1990 Evaluations. Part II-Toxicology, WHO/PCS/91/47 1991, World Health Organization, Geneva.
40. Food and Agriculture Organization/World Health Organization Pesticide Residues in Food: 1992 Evaluations. Part II-Toxicology, WHO/PCS/93.34 1993, World Health Organization, Geneva.
41. Food and Agriculture Organization/World Health Organization Pesticide Residues in Food: 1993 Evaluations. Part II-Toxicology, WHO/PCS/94.4 1994, World Health Organization, Geneva.
42. Ganendran A., Balabaskaran S. Reactivation studies on organophosphate inhibited human cholinesterases by pralidoxime (P-2-AM). Southeast Asian J. Trop. Med. Public Health 1976, 7:417-423.
43. Gibbon S.L., Tong H., Miranda P.M.S., Way J.L. Metabolism of pralidoxime (2-PAM) in man. J. Anal. Toxicol. 1979, 3:14-17.
44. Glickman A.H., Wing K.D., Casida J.E. Profenofos insecticide bioactivation in relation to antidote action and the stereospecificity of acetylcholinesterase inhibition, reactivation, and aging. Toxicol. Appl. Pharmacol. 1984, 73:16-22.
45. Gray L.E., Ostby J., Sigmon R., Ferrell J., Rehnberg G., Linder R., Cooper R., Goldman J., Laskey J. The development of a protocol to assess reproductive effects of toxicants in the rat. Reprod. Toxicol. 1988, 2:281-287.
46. Green M.D., Jones D.E., Hilmas D.E. Sarin intoxication elevates plasma pralidoxime. Toxicol. Lett. 1985, 28:17-21.
47. Green M.D., Talbot B.G., Clark C.R. Pharmacokinetics of pralidoxime chloride in the rat. Life Sci. 1986, 39:2263-2269.
48. Gupta R.C. Acute malathion toxicosis and related enzymatic alterations in Bubalus bubalis: Antidotal treatment with atropine, 2-PAM, and diazepam. J. Toxicol. Environ. Health 1984, 14:291-303.
49. Gupta R.C. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol. Mech. Methods 2004, 14:103-143.
50. Gupta R.C., Patterson G.T., Dettbarn W.-D. Acute tabun toxicity; Biochemical and histochemical consequences in brain and skeletal muscles of rat. Toxicology 1987, 46:329-341.
51. Gupta R.C., Patterson G.T., Dettbarn W.-D. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat. Fundam. Appl. Toxicol. 1991, 16:449-458.
52. Hansen M.E., Wilson B.W. Oxime reactivation of RB acetylcholinesterases for biomonitoring. Arch. Environ. Contam. Toxicol. 1999, 37:283-289.
53. 1 receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slice. Eur. J. Pharmacol. 2003, 471:97-104.
54. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., Nold J.B. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J. Neurol. Sci. 1990, 98:99-106.
55. Herman R.J., Wilkinson G.R. Disposition of diazepam in young and elderly subjects after acute and chronic dosing. Br. J. Clin. Pharmacol. 1996, 42:147-155.
56. Hillestad L., Hansen T., Melsom H., Drivenes A. Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clin. Pharmacol. Ther. 1974, 16:479-484.
57. Hinderling P.H., Gundert-Remy U., Schmidlin O. Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. I: Pharmacokinetics. J. Pharm. Sci. 1985, 74:703-710.
58. Hobbiger F. Reactivation of phosphorylated AChE. Handbuch Exp. Pharmakol. 1963, 15:921-988.
59. Inns R.H., Leadbeater L. The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J. Pharm. Pharmacol. 1983, 35:427-433.
60. International Programme on Chemical Safety Environmental Health Criteria 63. Organophosphorus Insecticides: A General Introduction 1986, World Health Organization, Geneva.
61. Jager B.V., Stagg G.N. Toxicity of diacetyl monoxime and of pyridine-2-aldoxime methiodide in man. Bull. Johns Hopkins Hosp. 1958, 102:203-211.
62. Johnson M.K., Vale J.A. Clinical management of acute organophosphate poisoning: An overview. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 528-535. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
63. Johnson S., Peter J.V., Thomas K., Jeyaseelan L., Cherian A.M. Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning. J. Assoc. Physicians India 1996, 44:529-531.
64. Jokanovic M., Maksimovic M. A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat. Arch. Toxicol. 1995, 70:119-123.
65. Jokanovic M., Petrovic R.M.S., Maksimovi M., Jovanovic D., Kosanovic M., Piperski V. Effects of atropine, trimedoxime and methylprednisolone on the development of organophosphate-induced delayed polyneuropathy in the hen. Exp. Toxicol. Pathol. 2001, 53:129-132.
66. Josselson J., Sidell F.R. Effect of intravenous thiamine on pralidoxime kinetics. Clin. Pharmacol. Ther. 1978, 24:95-100.
67. Joubert J., Joubert P.H. Chorea and psychiatric changes in organophosphate poisoning. S. Afr. Med. J. 1988, 74:32-34.
68. Joubert J., Joubert P.H., van der Spuy M., van Graan E. Acute organophosphate poisoning presenting with choreoathetosis. J. Toxicol. Clin. Tocicol. 1984, 22:187-191.
69. Jovanovic D. Pharmacokinetics of pralidoxime chloride. A comparative study in healthy volunteers and in organophosphorus poisoning. Arch. toxicol. 1989, 63:416-418.
70. Jovanovic D., Randjelovic S., Joksovic D. A case of unusual suicidal poisoning by the organophosphorus insecticide dimethoate. Hum. Exp. Toxicol. 1990, 9:49-51.
71. Kanto J., Virtanen R., Iisalo E., Maenpaa K., Liukko P. Placental transfer and pharmacokinetics of atropine after a single maternal intravenous and intramuscular administration. Acta Anaesthesiol. Scand. 1981, 25:85-88.
72. Karalliedde L., Szinicz L. Management of organophosphorus compound poisoning. Organophosphates and Health 2001, 257-293. Imperial College Press, London. L. Karalliedde, S. Feldman, J. Henry, T. Marrs (Eds.).
73. Karlsson B., Fredriksson S.-, Sellström., Algers G. The protective effect of nimodipine, a calcium antagonist, and its influence on soman clearance in the anaesthetized rabbit. J. Pharm. Pharmacol. 1994, 46:123-127.
74. Kassa J., Bajgar J. Treatment of the stressogenic effect of dichlorvos. Sb. Ved. Pr. Lek. Fak. Karlovy Univerzity Hradci Kralove 1994, 37:29-32.
75. Kassa J., Fusek J. Effect of Panpal pretreatment and antidotal treatment (HI-6 plus benactyzine) on respiratory and circulatory function in soman-poisoned rats. Hum. Exp. Toxicol. 1997, 16:563-569.
76. Kiderlen D., Worek F., Klimmek R., Eyer P. The phosphoryl oxime-destroying activity of human plasma. Arch. Toxicol. 2000, 74:27-32.
77. Kleinrok Z., Jagiello-Wojtowicz E. Wplyw wybranych leków przeciwpadaczkowych na toksyncznosc ostra estru dwuizopropylowego kwasu fluorofosforowego u myszy. Ann. Univ. Mariae Curie Sklodowska 1977, 32:155-160.
78. Klimmek R., Eyer P. Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs. Arch. Toxicol. 1986, 59:272-278.
79. Klotz U., Avant G.R., Hoyumpa A., Schenker S., Wilkinson G.R. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J. Clin. Invest. 1975, 55:347-359.
80. Klotz U., Antonin K.H., Bieck P.R. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J. Pharmacol. Exp. Ther. 1976, 199:67-73.
81. Kondritzer A.A., Zvirblis P., Goodman A., Paplanus S.H. Blood plasma levels and elimination of salts of 2-PAM in man after oral administration. J. Pharm. Sci. 1968, 57:1142-1146.
82. Krutak-Krol H., Domino E.F. Comparative effects of diazepam and midazolam on paraoxon toxicity in rats. Toxicol. Appl. Pharmacol. 1985, 81:545-550.
83. Kuhnen H. Activating and inhibitory effects of bispyridinium compounds on bovine red cell acetylcholinesterase. Toxicol. Appl. Pharmacol. 1971, 20:97-104.
84. Kusic R., Jovanovic D., Randjelovic S., Joksovic D., Todorovic V., Boskovic B., Jokanovic M., Vojvodic V. HI-6 in man: Efficacy of the oxime in poisoning by organophosphorus insecticides. Hum. Exp. Toxicol. 1991, 10:113-118.
85. Lallement G., Renault F., Baubichon D., Peoc'h M., Burckhart M.-F., Galonnier M., Clarencon D., Jourdil N. Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: Relationship to plasmatic benzodiazepine pharmacokinetics. Arch. Toxicol. 2000, 74:480-486.
86. Langenberg J.P., DeJong I.P.A., Otto M.F., Benschop H.P. Spontaneous and oxime induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Arch. Toxicol. 1988, 62:305-310.
87. Leader H., Vincze A., Manisterski B., Rothschild N., Dosoretz C., Ashani Y. Characterization of O, O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases. Biochem. Pharmacol. 1999, 58:503-515.
88. LeBlanc F.N., Benson B.E., Gilg A.D. A severe organophosphate poisoning requiring the use of an atropine drip. J. Toxicol. Clin. Toxicol. 1986, 24:69-76.
89. Lekeux P., Kyavu A., Clercx C., Ansay M. Pulmonary function changes induced by experimental dichlorvos toxicosis in calves. Res. Vet. Sci. 1986, 40:318-321.
90. Ligtenstein D.A., Kossen S.P. Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration to the rat. Toxicol. Appl. Pharmacol. 1983, 71:177-183.
91. Lipp J.A. Effect of small doses of clonazepam upon soman-induced seizure activity and convulsions. Arch. Int. Pharmacodyn. 1974, 210:49-54.
92. Loomis T.A. Distribution and excretion of pyridine-2-aldoxime methiodide (PAM); Atropine and PAM in sarin poisoning. Toxicol. Appl. Pharmacol. 1963, 5:489-499.
93. Lüttringhaus A., Hagedorn I. Quatäre Hydroxyiminomethyl-pyridinium-salze. Das Dichlorid des Bis-[4-hydroxyiminomethyl-pyridinium-(1)-methyl]-äthers] ("LüH 6"), ein neuer Reaktivator der durch organische Phosphorsäureester gehemmten Acetylcholin-Esterase. Arzneimittelforschung 1964, 14:1-5.
94. Mandelli M., Tognoni G., Garattini S. Clinical pharmacokinetics of diazepam. Clin. Pharmacokinet. 1978, 3:72-91.
95. Marrs T.C. Toxicology of oximes used in the treatment of organophosphate poisoning. Adverse Drug React. Toxicol. Rev. 1991, 10:61-72.
96. Marrs T.C. Organophosphates: History, chemistry, pharmacology. Organophosphates and Health 2001, 1-36. Imperial College Press, London. L. Karalliedde, S. Feldman, J. Henry, T. Marrs (Eds.).
97. Marrs T.C. Diazepam in the treatment of organophosphorus ester pesticide poisoning. Toxicol. Rev. 2003, 22:75-81.
98. Martí J., Reverté C., Roig M., Pascual I., Prats J. Uso del diacepam en la intoxicación por insecticidas organofosforados. An. Esp. Pediatr. 1985, 23:299-301.
99. Mason H.J., Waine E., Stevenson A., Wilson H.K. Aging and spontaneous reactivation of human plasma cholinesterase activity after inhibition by organophosphorus pesticides. Hum. Exp. Toxicol. 1993, 12:497-503.
100. Mason H.J., Sams C., Stevenson A.J., Rawbone R. Rates of spontaneous reactivation and aging of acetylcholinesterase in human erythrocytes after inhibition by organophosphorus pesticides. Hum. Exp. Toxicol. 2000, 19:511-516.
101. Maxwell D.M., Saxena A., Gordon R.K., Doctor B.P. Improvements in scavenger protection against organophosphorus agent by modification of cholinesterases. Chem.-Biol. Interact. 1999, 119-120:419-428.
102. McGuinn W.D., Cannon E.P., Chui C.T., Pei L., Petrikovics I., Way J.L. The encapsulation of squid diisopropylphosphorofluoridate-hydrolyzing enzyme within mouse erythrocytes. Fundam. Appl. Toxicol. 1993, 21:38-43.
103. Medicis J.J., Stork C.M., Howland M.A., Hoffman R.S., Goldfrank L.R. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers. J. Toxicol. Clin. Toxicol. 1996, 34:289-295.
104. Merrill D.G., Mihm F.G. Prolonged toxicity of organophosphate poisoning. Crit. Care Med. 1982, 10:550-551.
105. Namba T., Nolte C.T., Jackrel J., Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am. J. Med. 1971, 50:475-492.
106. Nenner M. Phosphonylierte Aldoxime. Hemmwirkung auf Acetylcholinesterase und hydrolytischer Abbau. Biochem. Pharmacol. 1974, 23:1255-1262.
107. Ortells M.O., Lunt G.G. Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 1995, 18:121-127.
108. Pei L., Petrikovics I., Way J.L. Antagonism of the lethal effects of paraoxon by carrier erythrocytes containing phosphotriesterase. Fundam. Appl. Toxicol. 1995, 28:209-214.
109. Petrovic R.M., Jokanovic M., Maksimovic M., Ugresic N., Boskovic B. The treatment of delayed polyneuropathy induced by diisopropylfluorophosphate in hens. Pharmazie 2000, 55:454-455.
110. Pieri L., Schaffner R., Scherschlicht R., Polc P., Sepinwall J., Davidson A., Möhler H., Cumin R., Da Prada M., Burkard W.P., Keller H.H., Müller R.K.M., Gerold M., Pieri M., Cook L., Haefely W. Pharmacology of midazolam. Arzneimittelforschung 1981, 31:2180-2201.
111. Raveh L., Chapman S., Cohen G., Alkalay D., Gilat E., Rabinovitz I., Weissman B.A. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. NeuroToxicology 1999, 20:551-559.
112. Raveh L., Brandeis R., Gilat E., Cohen G., Alkalay D., Rabinovitz I., Sonego H., Weissman B.A. Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction. Toxicol. Sci. 2003, 75:108-116.
113. Rivero González A., Navarro González J.F., Macía Heras M.L., Mora Fernández C., Rodríguez Serrano M.L., García Pérez J. Intoxicación por paraquat: Presentación de dos casos y revisión de la literatura. An. Med. Int. 2001, 18:208-210.
114. Rump S., Grudzinska E. Investigation on the effects of diazepam in acute experimental intoxication with fluostigmine. Arch. Toxikol. 1974, 31:223-232.
115. Sakurada K., Matsubara K., Shimizu K., Shiono H., Seto Y., Tsuge K., Yoshino M., Sakai I., Mukoyama H., Takatori T. Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem. Res. 2003, 28:1401-1407.
116. Sanderson D.M. Treatment of poisoning by anticholinesterase insecticides in the rat. J. Pharm. Pharmacol. 1961, 13:435-442.
117. Schexnayder S., James L.P., Kearns G.L., Farrar H.C. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J. Toxicol. Clin. Toxicol. 1998, 36:549-555.
118. Sellström Anticovulsants in anticholinesterase poisoning. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 578-586. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
119. Senanayake N., Karalliedde L. Neurotoxic effects of organophosphorus insecticides: An intermediate syndrome. N. Engl. J. Med. 1987, 316:761-763.
120. Shih T.-M., McDonough J.H. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol. Biochem. Behav. 1999, 64:147-153.
121. ShiloffJ.D., Clement J.G. Comparison of serum concentrations of the acetylcholinesterase oxime reactivators HI-6, obidoxime, and PAM to efficacy against sarin (isopropyl methylphosphonofluridate) poisoning in rats. Toxicol. Appl. Pharmacol. 1987, 89:278-280.
122. Sidell F.R., GroffW.A. Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man. J. Pharm. Sci. 1971, 60:1224-1228.
123. Sidell F.R., GroffW.A., Kaminskis A. Pralidoxime methanesulfonate: Plasma levels and pharmacokinetics after oral administration to man. J. Pharm. Sci. 1972, 61:1136-1140.
124. Sidell F.R., GroffW.A., Kaminskis A. Toxogonin and pralidoxime: Kinetic comparison after intravenous administration to man. J. Pharm. Sci. 1972, 61:1765-1769.
125. Simon F.A., Pickering L.K. Acute yellow phosphorus poisoning: "Smoking stool syndrome". J. Am. Med. Assoc. 1976, 235:1343-1344.
126. Skrinjaric-Spoljar M., Simeon V., Reiner E. Spontaneous reactivation and aging of dimethylphosphorylated AChE and cholinesterase. Biochim. Biophys. Acta 1973, 315:363-369.
127. 2 receptor effects on mechanics of ventilation and gas exchange in neonatal calves. Am. J. Vet. Res. 1981, 42:764-769.
128. Smith D.M. Organophosphorus poisoning from emergency use of a handsprayer. Practitioner 1977, 218:877-883.
129. St. Omer V.E.V., Rottinghaus G.E. Biochemical determination of chloinesterase activity in biological fluids and tissues. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 15-27. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
130. Sterling G.H., Doukas P.H., Sheldon R.J., O'Neill J.J. In vivo protection against soman toxicity by known inhibitors of acetylcholine synthesis in vitro. Biochem. Pharmacol. 1988, 37:379-384.
131. Sudakin D.L., Mullins M.E., Horowitz B.Z., Abshier V., Letzig L. Intermediate syndrome aftermalathion ingestion despite continuous infusion of pralidoxime. J. Toxicol. Clin. Toxicol. 2000, 38:47-50.
132. Sundwall A. Minimum concentrations of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block. Biochem. Pharmacol. 1961, 8:413-417.
133. Swaminathan M., Widdop B. Biochemical and toxicological investigations related to OP compounds. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 357-406. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
134. Swartz R.D., Sidell F.R. Effects of heat and exercise on the elimination of pralidoxime in man. Clin. Pharmacol. Ther. 1973, 14:83-89.
135. Thiermann H., Mast U., Klimmek R., Eyer P., Hibler A., Pfab R., Felgenhauer N., Zilker T. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum. Exp. Toxicol. 1997, 16:473-480.
136. Thiermann H., Szinicz L., Eyer F., Worek F., Eyer P., Felgenhauer N., Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol. Lett. 1999, 107:233-239.
137. Tuovinen K. Organophosphate-induced convulsions and prevention of neuropathological damages. Toxicology 2004, 196:31-39.
138. Tush G.M., Anstead M.I. Pralidoxime continuous infusion in the treatment of organophosphate poisoning. Ann. Pharmacother. 1997, 31:441-444.
139. Uehara S., Hiromori T., Isobe N., Suzuki T., Kato T., Miyamoto J. Studies on the therapeutic effect of 2-pyridine aldoxime methiodide (2-PAM) in mammals following organophosphorus compound-poisoning (report III): Distribution and antidotal effect of 2-PAM in rats. J. Toxicol. Sci. 1993, 18:265-275.
140. Vale J.A., Scott G.W. Organophosphorus poisoning. Guy's Hosp. Rep. 1974, 123:13-25.
141. Van der Meer M.J., Hundt H.K.L., Muller F.O. Inhibition of atropine metabolism by organophosphate pesticides. Hum. Toxicol. 1983, 2:637-640.
142. Van Helden H.P.M., Van der Wiel H.J., Zijlstra J.J., Melchers B.P.C., Busker R.W. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following nonreactivatable acetylcholinesterase inhibition in rats. Arch. Toxicol. 1994, 68:224-230.
143. Van Helden H.P.M., Busker R.W., Melchers B.P.C., Bruijnzeel P.L.B. Pharmacological effects of oximes: How relevant are they?. Arch. Toxicol. 1996, 70:779-786.
144. Van Helden H.P.M., Groen B., Moor E., Westerink B.H.C., Bruijnzeel P.L.B. New generic approach to the treatment of organophosphate poisoning: Adenosine receptor mediated inhibition of ACh-release. Drug Chem. Toxicol. 1998, 21:171-181.
145. Virtanen R., Kanto J., Iisalo E., Iisalo E.U.M., Salo M., Sjovall S. Pharmacokinetic studies on atropine with special reference to age. Acta Anaesthesiol. Scand. 1982, 26:297-300.
146. Vojvodic V.B., Maksimovic M. Absorption and excretion of pralidoxime in man after intramuscular injection of PAM-2Cl and various cholinolytics. Eur. J. Clin. Pharmacol. 1972, 5:58-61.
147. von Erdmann W.D., Engelhart H. Pharmakologisch-toxikologisch Untersuchungen mit dem Dichlorid des Bis-(4-hydroxyiminomethyl-pyridinium-(1)-methyl-äthers, eine neuen esterase-Reaktivator 1964, Unknown.
148. Wedin G.P. Comment: Anticholinesterase insecticide reactions. Drug Intel. Clin. Pharm. 1988, 22:919-920.
149. Wehner J.M., Smolen A., Smolen T.N., Murphy C. Recovery of acetylcholinesterase activity after acute organophosphate treatment of CNS reaggregate cultures. Fundam. Appl. Toxicol. 1985, 5:1104-1109.
150. Weissmann-Brenner A., David A., Vidan A., Hourvitz A. Organophosphate poisoning: A multihospital survey. Isr. Med. Assoc. J. 2002, 4:573-576.
151. Willems J.L., Belpaire F.M. Anticholinergic poisoning: An overview of pharmacotherapy. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 536-542. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
152. Willems J.L., De Bisschop H.C., Verstraete A.G., Declerck C., Christiaens Y., Vanscheeuwyck P., Buylaert W.A., Vogelaers D., Colardyn F. Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphate. Arch. Toxicol. 1993, 67:79-84.
153. Wilson B.H., Hooper M.J., Hansen M.E., Nieberg P.S. Reactivation of organophosphorus inhibited AChE with oximes. Organophosphates-Chemistry, Fate and Effects 1992, 107-137. Academic Press, San Diego. J.E. Chambers, P.E. Levi (Eds.).
154. Wilson I.B., Ginsburg S. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochim. Biophys. Acta 1955, 18:168-170.
155. Wing K.D., Glickman A.H., Casida J.E. Phosphorothioate pesticides and related compounds: Oxidative bioactivation and aging of the inhibited AChE. Pestic. Biochem. Physiol. 1984, 21:22-30.
156. Wirth W. Schädigungsmöglichkeiten durch Antidote. Arch. Toxikol. 1968, 24:71-82.
157. Wolfe A.D. AChE sequestration of organophosphate intoxicants. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 596-601. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
158. Wolfe A.D., Rush R.S., Doctor B.P., Koplovitz I., Jones D. Acetylcholinesterase prophylaxis against organophosphate toxicity. Fundam. Appl. Toxicol. 1987, 9:266-270.
159. Worek F., Kirchner T., Bäcker M., Szinicz L. Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch. Toxicol. 1996, 70:497-503.
160. Worek F., Bäcker M., Thiermann H., Szinicz L., Mast U., Klimmek R., Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum. Exp. Toxicol. 1997, 16:466-472.
161. Worek F., Diepold C., Eyer P. Dimethylphosphoryl-inhibited human cholinesterases: Inhibition, reactivation, and aging kinetics. Arch. Toxicol. 1999, 73:7-14.
162. Yacoub M., Skouri H., Amamou M., Besencenot F. Intoxications aiguës par les insecticides organo-phosphorés. A propos de 908 cas observés au Centre Anti-Poisons de Tunis. J. Toxicol. Med. 1981, 1:165-188.
163. Zilker T., Hibler A. Treatment of severe parathion poisoning: Clinical aspects. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning 1996, 9-17. Spektrum Akademischer Verlag, Heidelberg. L. Szinicz, P. Eyer, R. Klimmek (Eds.).
164. Zilker T., Felgenhauer N., Hibler A., Pfab R., Thiermann H., Worek F., Eyer P. Factors influencing the efficacy of obidoxime in organophosphate pesticides poisoning. Przegl. Lek. 1997, 54:662-664.